Generics

Filter

Current filters:

None

Popular Filters

1001 to 1025 of 1176 results

Patent losses will drive generics in cardiovascular diseases market to 2018

27-05-2012

The global generics market cardiovascular drugs is expected to grow rapidly due to the growing dyslipdemia,…

Cardio-vascularGenericsMarkets & MarketingPatents

Takeda to acquire Brazil's Multilab for around $249 million

25-05-2012

Takeda Pharmaceutical (TYO: 4502), Japan's largest drugmaker, revealed this morning that it has entered…

GenericsMergers & AcquisitionsMultilabPharmaceuticalSouth AmericaTakeda Pharmaceuticals

Teva lowers full-year 2012 forecasts

25-05-2012

Israel-based generic drug major Teva Pharmaceutical Industries (Nasdaq: TEVA) has provided its current…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Current pharma pricing policy will hurt both patients and industry in the long run, assert pharma experts

25-05-2012

Pharmaceutical analysts in India and the UK believe cost-based pricing is not suitable to safeguard the…

GenericsGlobalHealthcarePharmaceuticalPricing

Australia's TGA launches consultation on better medicines labeling

24-05-2012

Australia's medicine's regulator, the Therapeutic Goods Administration, has this week released a consultation…

Asia-PacificBiotechnologyGenericsPharmaceuticalRegulation

Scientists say new process would make anti-malarial drug less costly

24-05-2012

Scientists are reporting development of a new, higher-yield, two-step, less costly process that may ease…

artemisininGenericsPricingResearchTropical diseases

Suneva Medical acquires product portfolio from Spear Pharma

24-05-2012

Privately-held US aesthetics company Suneva Medical has acquired an aesthetic product portfolio from…

DermatologicalsGenericsMergers & AcquisitionsPharmaceuticalRefissaSpear PharmaceuticalsSuneva MedicalTretinoin

Tanzanian drugmaker to start producing ARVs in August

23-05-2012

Tanzania Pharmaceutical Industries (TPI) was due to start productions earlier this year, but finalization…

Anti-viralsGenericsMarkets & MarketingPharmaceuticalRest of the WorldTanzania Pharma Industries

Pros and cons of pharmaceutical manufacturing in China and India

22-05-2012

The current global environment is forcing all pharmaceutical companies to improve their efficiency and…

Asia-PacificGenericsMarkets & MarketingPharmaceutical

Erythropoietin market in Japan to reach $1.54 billion by 2015

20-05-2012

The erythropoietin market in Japan is forecast to reach $1.54 billion by 2015 by analysts at TechNavio.…

Asia-PacificBiotechnologyGenericsMarkets & MarketingNephrology and HepatologyPatents

US FDA approves generic versions of blood thinner Plavix

18-05-2012

Coinciding with the loss of patent protection on Sanofi (Euronext: SAN) and Bristol-Myers Squibb's (NYSE:…

Cardio-vascularClopidogrelDr Reddy's LaboratoriesGenericsMylan LaboratoriesNorth AmericaPlavixRegulation

Bristol-Myers anticipates significant decline in US clopidogrel sales as patent lapses

17-05-2012

GenericsWeb, a patent analysis and search company, recently published an article based on its proprietary…

Bristol-Myers SquibbCardio-vascularClopidogrelGenericsPatentsPharmaceuticalPlavixSanofi

Biosimilars can save eight EU countries up to 33 billion euros on health care by 2020

16-05-2012

By 2020, eight countries in the European Union could save a cumulative total of between 11.8 billion…

BiotechnologyEuropeGenericsHealthcareNovartisPricingSandoz

Hikma may invest $100 million in Ukrainian pharma market

15-05-2012

Hikma Pharmaceuticals (LSE: HIK), Jordan's largest pharmaceutical company which is listed on the London…

EuropeFinancialGenericsHikma Pharmaceuticals

Dr Reddy's sees FY2011/12 sales rise 30%

14-05-2012

India's second-largest drugmaker, Dr Reddy's Laboratories (NYSE: RDY) posted full year ended March 31,…

Dr Reddy's LaboratoriesFinancialGenerics

Mylan starts selling generic Lipitor in Europe; to buy back shares

14-05-2012

US generic drug major Mylan's (Nasdaq: MYL) shares 2.2% to $21.55 in morning last Friday after the company…

atorvastatinCardio-vascularEuropeFinancialGenericsLipitorMarkets & MarketingMylan Laboratories

EU draft opinion on ACTA still flawed, says MSF, urging member states not to sign

11-05-2012

The European Union Parliament Committee on Development released its draft opinion this week on the Anti-Counterfeiting…

EuropeGenericsGlobalPatentsPharmaceuticalPolitics

Ranbaxy sales rocket 55%, net rises four-fold

11-05-2012

Ranbaxy Laboratories (AB: BO), India's largest drugmaker, came in with a stompingly good set of financial…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

Stada Arz reports solid start to 2012

10-05-2012

German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) reported first-quarter 2012 financial…

FinancialGenericsPharmaceuticalSTADA Arzneimittel

High expectations for new US biosimilars following FDA guidance documents

10-05-2012

In light of the upcoming FDA guidance for biosimilar approval, Novation, health care supply chain expertise…

BiotechnologyGenericsNorth AmericaPricingRegulation

1001 to 1025 of 1176 results

Back to top